FY2023 EPS Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Raised by Analyst themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Nomura Asset Management Co. Ltd. lifted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 68,017 shares of the biopharmaceutical company’s stock after purchasing an additional 1,804 shares during the quarter. […]
William Blair reaffirmed their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday morning, RTT News reports. A number of other equities analysts have also weighed in on ALNY. Citigroup decreased their target price on Alnylam Pharmaceuticals from $266.00 to $233.00 and set a […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty analysts that are covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among […]
Wells Fargo & Company initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report issued on Friday morning, Marketbeat reports. The brokerage issued an equal weight rating and a $171.00 target price on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. BMO Capital Markets reduced […]